Literature DB >> 1335128

Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors.

A A Parsons1, C Stutchbury, P Raval, A J Kaumann.   

Abstract

The effects of 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), methysergide and sumatriptan were studied on endothelium-denuded rings of beagle dog large coronary arteries. Submicromolar concentrations of the compounds contracted the rings with the order of potency 5-CT > 5-HT > sumatriptan = methysergide. Concentrations greater than 2 microM of both 5-HT and 5-CT, and 60 mumol/l methysergide also caused concentration-dependent relaxation. Sumatriptan did not cause relaxation. Peak intrinsic activities relative to the plateau contraction to sumatriptan (1.00), were 5-CT 0.47, 5-HT 0.87 and methysergide 0.51. Ketanserin 1 mumol/l affected neither contractile responses nor relaxant responses to 5-CT, methysergide and sumatriptan and only caused marginal blockade of the contractile effects of 5-HT. Methiothepin 200 nM shifted the concentration-contractile response curves by around 2 log units, as expected from its affinity for 5-HT1-like receptors. The rank order of contractile potency of the agonists, the antagonism by methiothepin and the resistance to blockade by ketanserin are consistent with a nearly exclusive involvement of 5-HT1-like receptors. Isolated large coronary arteries from beagle dogs may be a suitable model for the study of human coronary artery 5-HT1-like receptors that are involved in the spasm observed with 5-HT and sumatriptan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335128     DOI: 10.1007/bf00169018

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Coronary vasospasm induced by subcutaneous sumatriptan.

Authors:  F Willett; N Curzen; J Adams; M Armitage
Journal:  BMJ       Date:  1992-05-30

Review 2.  A subfamily of 5-HT1D receptor genes.

Authors:  P R Hartig; T A Branchek; R L Weinshank
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

3.  Selective amplification and cloning of four new members of the G protein-coupled receptor family.

Authors:  F Libert; M Parmentier; A Lefort; C Dinsart; J Van Sande; C Maenhaut; M J Simons; J E Dumont; G Vassart
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

4.  Convenient apparatus for recording contractions of isolated heart muscle.

Authors:  J R Blinks
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

5.  5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.

Authors:  P Schoeffter; D Hoyer
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

6.  5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries.

Authors:  A H Chester; G R Martin; M Bodelsson; B Arneklo-Nobin; S Tadjkarimi; K Tornebrandt; M H Yacoub
Journal:  Cardiovasc Res       Date:  1990-11       Impact factor: 10.787

7.  5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation.

Authors:  H E Connor; W Feniuk; P P Humphrey
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

8.  Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors.

Authors:  R M Brazenor; J A Angus
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

9.  A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.

Authors:  A J Kaumann; M Frenken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

10.  Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

View more
  4 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.

Authors:  P Gupta; D Brown; P Butler; P Ellis; K L Grayson; G C Land; J E Macor; S F Robson; M J Wythes; N B Shepperson
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

3.  Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.

Authors:  J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.

Authors:  A Choppin; S E O'Connor
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.